Joseph E Turk Jr
CIK 1341403 · President · last filed 2025-08-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NXTM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
439 SOUTH UNION STREET 5TH FLOOR
LAWRENCE, MA 01843
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LFWD | Director | 8,748 | $6.04 | $52.8K | $50.2K | 3 | 2025-08-07 |
| Lifeward Ltd. (RWLK) Delisted | Director | 133,946 | $1.05 | $140.7K | $21.4K | 5 | 2023-09-19 |
| NxStage Medical, Inc. (NXTM) Delisted | President | 86,401 | — | — | -$13.26M | 154 | 2018-05-21 |
Recent Filings · Page 12 of 17
163 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-07-19 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | −2,250 | -$56.4K | EDGAR |
| 2012-07-03 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | — | -$29.7K | EDGAR |
| 2012-06-21 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | −2,250 | -$57.8K | EDGAR |
| 2012-05-23 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | −2,250 | -$56.4K | EDGAR |
| 2012-04-25 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | −2,250 | -$76.6K | EDGAR |
| 2012-04-06 | NxStage Medical, Inc. (NXTM) Delisted | Sell (S) | −652 | -$12.3K | EDGAR |
| 2012-03-29 | NxStage Medical, Inc. (NXTM) Delisted | Sell (S) | −652 | -$12.8K | EDGAR |
| 2012-03-22 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | −2,902 | -$103.3K | EDGAR |
| 2012-03-14 | NxStage Medical, Inc. (NXTM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-03-13 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | +6,135 | -$52.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.